Russian Health Ministry Approves Use Of Areplivir Drug For COVID-19 Treatment
Faizan Hashmi Published June 25, 2020 | 11:00 PM
MOSCOW (UrduPoint News / Sputnik - 25th June, 2020) The Russian Health Ministry approved the use of Favipiravir-based drug Areplivir manufactured by pharmaceutical company Promomed for treatment of coronavirus patients, according to information in the state medicines' registry.
"The trade name of the drug is Areplivir. The international non-proprietary or grouping or chemical name is Favipiravir," the registry says.
Recent Stories
Bugti assures transporters for addressing their problems
10 hours ago
Deputy Prime Minister and Foreign Minister, Mohammad Ishaq Dar meets foreign min ..
10 hours ago
3 drug peddlers arrested, hashish recovered
10 hours ago
1496,990 children given polio drops in five days: DC
10 hours ago
Six terrorists killed, hideout busted in N Waziristan IBO: ISPR
10 hours ago
Pakistan, Qatar agree to further expand trade, investment ties
11 hours ago
Sindh cabinet approves Rs177.5m to strengthen, mobilize various wings of police
10 hours ago
Faisal Karim Kundi takes oath as new KP Governor
10 hours ago
Azad Jammu and Kashmir Prime Minister Anwaar ul Haq Chaudhry seeks more vibrant ..
10 hours ago
Tahaffuz Manzil Foster Home providing care & support to homeless children
10 hours ago
PCB proposes April 7 -May 20 window; tweaks in rules for HBL PSL 2025
11 hours ago
Field hospitals now operational across Punjab: Azma Bukhari
10 hours ago